We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Nelnet
NNI
$4.7B
| $2M | ﹤0.01% |
41,807
+666
| +2% | +$31.2K |
|
1727
Scansource
SCSC
$1.12B
| $1.99M | ﹤0.01% |
82,785
-8,836
| -10% | -$209K |
|
1728
JELD-WEN Holding
JELD
$164M
| $1.99M | ﹤0.01% |
123,647
+28,290
| +30% | +$373K |
|
1729
Tootsie Roll Industries
TR
$2.98B
| $1.99M | ﹤0.01% |
69,300
+2,260
| +3% | +$67.1K |
|
|
SCS
1730
DELISTED
Steelcase
SCS
| $1.99M | ﹤0.01% |
164,682
+14,042
| +9% | +$154K |
|
|
PGRE
1731
DELISTED
Paramount Group
PGRE
| $1.99M | ﹤0.01% |
257,426
+18,743
| +8% | +$158K |
|
1732
Heron Therapeutics
HRTX
$92.9M
| $1.98M | ﹤0.01% |
134,826
+17,110
| +15% | +$281K |
|
|
HNGR
1733
DELISTED
Hanger Inc.
HNGR
| $1.98M | ﹤0.01% |
119,773
-8,334
| -7% | -$141K |
|
1734
Champion Homes
SKY
$5.14B
| $1.98M | ﹤0.01% |
81,357
+10,734
| +15% | +$224K |
|
|
TBI
1735
Trueblue
TBI
$311M
| $1.98M | ﹤0.01% |
129,546
-15,777
| -11% | -$234K |
|
1736
Atkore
ATKR
$3.16B
| $1.98M | ﹤0.01% |
72,270
+10,551
| +17% | +$261K |
|
1737
Verra Mobility
VRRM
$744M
| $1.97M | ﹤0.01% |
191,571
+28,547
| +18% | +$270K |
|
1738
Amphastar Pharmaceuticals
AMPH
$916M
| $1.97M | ﹤0.01% |
87,632
-5,727
| -6% | -$105K |
|
1739
United Fire Group
UFCS
$1.4B
| $1.97M | ﹤0.01% |
70,939
-7,564
| -10% | -$213K |
|
|
ICPT
1740
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.97M | ﹤0.01% |
41,045
+4,603
| +13% | +$356K |
|
1741
National Presto Industries
NPK
$989M
| $1.97M | ﹤0.01% |
22,484
-712
| -3% | -$60.6K |
|
1742
Westlake Corp
WLK
$9.9B
| $1.97M | ﹤0.01% |
36,619
-2,908
| -7% | -$134K |
|
|
VVNT
1743
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $1.96M | ﹤0.01% |
+113,097
| New | +$1.42M |
|
|
MFA
1744
MFA Financial
MFA
$933M
| $1.96M | ﹤0.01% |
196,280
+80,417
| +69% | +$622K |
|
1745
Matthews International
MATW
$739M
| $1.95M | ﹤0.01% |
102,322
-13,355
| -12% | -$285K |
|
1746
Clearwater Paper
CLW
$376M
| $1.95M | ﹤0.01% |
54,029
-6,404
| -11% | -$178K |
|
1747
TriMas Corp
TRS
$1.44B
| $1.95M | ﹤0.01% |
81,421
-1,824
| -2% | -$41.9K |
|
1748
Liberty Latin America Class C
LILAK
$1.64B
| $1.95M | ﹤0.01% |
240,939
+6,443
| +3% | +$54.8K |
|
1749
RadNet
RDNT
$5.69B
| $1.94M | ﹤0.01% |
122,163
-10,734
| -8% | -$155K |
|
1750
RE/MAX Holdings
RMAX
$242M
| $1.94M | ﹤0.01% |
61,574
-5,712
| -8% | -$152K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.